Henan Lingrui Pharmaceutical. 

¥21.18
1
+¥0.1+0.47% Today

Statistics

Day High
21.2
Day Low
21
52W High
24.7
52W Low
20.52
Volume
1,536,809,000
Avg. Volume
-
Mkt Cap
12.01B
P/E Ratio
15.33
Dividend Yield
4.27%
Dividend
0.9

Upcoming

Dividends

4.27%Dividend Yield
Jun 25
¥0.9
Jun 24
¥0.8
Jun 23
¥0.6
Jun 22
¥0.5
Jun 21
¥0.4
10Y Growth
19.62%
5Y Growth
17.61%
3Y Growth
14.47%
1Y Growth
N/A

Earnings

30OctExpected
Q3 2022
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
0.24
0.57
0.9
1.24
Expected EPS
N/A
Actual EPS
N/A

Financials

20.93%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
6.91BRevenue
1.45BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 600285.SHG. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules; and Tongluo pain relief creams, Huoxuexiaotong tinctures, bone strengthening musk pain relief creams, indomethacin patches, abdominal soothing plasters, children's paracetamol and phenylephrine granules, children's kechuanling granules, montmorillonite powders, medical cooling patches, three yellow pearl creams, mometasone furoate creams, mupirocin ointments, bluestone particles, ke ning capsules, xiao chaihu tablets, and ruishuan fentanyl transdermal patches. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.
Show more...
CEO
Mr. Wei Xiong
Employees
2435
Country
China
ISIN
CNE000001501

Listings

0 Comments

Share your thoughts

FAQ

What is Henan Lingrui Pharmaceutical. stock price today?
The current price of 600285.SHG is ¥21.18 CNY — it has increased by +0.47% in the past 24 hours. Watch Henan Lingrui Pharmaceutical. stock price performance more closely on the chart.
What is Henan Lingrui Pharmaceutical. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Henan Lingrui Pharmaceutical. stocks are traded under the ticker 600285.SHG.
Is Henan Lingrui Pharmaceutical. stock price growing?
600285.SHG stock has fallen by -1.72% compared to the previous week, the month change is a -5.82% fall, over the last year Henan Lingrui Pharmaceutical. has showed a -7.15% decrease.
What is Henan Lingrui Pharmaceutical. market cap?
Today Henan Lingrui Pharmaceutical. has the market capitalization of 12.01B
What is Henan Lingrui Pharmaceutical. revenue for the last year?
Henan Lingrui Pharmaceutical. revenue for the last year amounts to 6.91B CNY.
What is Henan Lingrui Pharmaceutical. net income for the last year?
600285.SHG net income for the last year is 1.45B CNY.
Does Henan Lingrui Pharmaceutical. pay dividends?
Yes, 600285.SHG dividends are paid annual. The last dividend per share was 0.9 CNY. As of today, Dividend Yield (FWD)% is 4.27%.
How many employees does Henan Lingrui Pharmaceutical. have?
As of April 20, 2026, the company has 2,435 employees.
In which sector is Henan Lingrui Pharmaceutical. located?
Henan Lingrui Pharmaceutical. operates in the Health & Wellness sector.
When did Henan Lingrui Pharmaceutical. complete a stock split?
The last stock split for Henan Lingrui Pharmaceutical. was on July 02, 2014 with a ratio of 1.5:1.
Where is Henan Lingrui Pharmaceutical. headquartered?
Henan Lingrui Pharmaceutical. is headquartered in Xinyang, China.